Coello VJS, Chávez RJG, Valdivieso DAC

Language: Spanish
References: 29
Page: 138-146
PDF size: 274.53 Kb.

ABSTRACT

Patients with symptoms of unstable angina who attend the emergency area; come with a clinical picture of more than 12 hours of evolution and are subjected to this type of treatment to improve their clinic. Objective: To assess whether invasive angioplasty treatment is effective in patients with unstable angina more than 12 hours of evolution. Material and methods: Observational, descriptive, correlational cross-sectional study of prevalence, comprised of clinical records of 283 patients who underwent angioplasty is the period 2012-2015. Demographic and clinical characteristics were recorded, medication use. Results were analyzed during the hospital stay and late one month, 6 months and one year. Results: The universe consisted of 283 patients admitted to the emergency area for acute coronary syndrome who underwent the treatment of invasive angioplasty. The sample consists of 99 patients diagnosed with unstable angina of more than 12 hours of evolution, of which 75 (75.8%) are male; 24 (24.2%) are female. The post-intervention complications were, on average, 24.24%, with a mortality rate of less than 1%. Conclusion: This study confirms that angioplasty is effective for treating patients with unstable angina with a clinic more than 12 hours of evolution therapeutic procedure.

REFERENCES

1. Swahn E, Alfredsson J. Invasive treatment of acute coronary syndrome without ST segment elevation Cardiac catheterization/revascularization in all cases? Rev Esp Cardiol. 2014; 67: 218-221. doi: 10.1016/j.recesp.2013.11.003

2. Hoenig MR, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev. 2010; 17 (3): CD004815. doi: 10.1002/14651858.CD004815.pub3

3. Serrano GR, Pérez TJ, Pino SE. Clinical evolution of patients with AMI treated with primary angioplasty. CorSalud. 2012; 4 (3): 157-157-165.

4. Vale N, Nordmann AJ, Schwartz GG, de Lemos J, Colivicchi F, den Hartog F et al. Statins for acute coronary syndrome. Statins for acute coronary syndrome. Cochrane Database Syst Reviews. 2014; 9. Art. O: CD006870. doi: 10.1002/14651858.CD006870.pub3

5. Wald D, Morris JK, Wald NJ, Chase JA, Edwards RJ, Hughes LO et al. Randomized study of preventive angioplasty in myocardial infarction. N Engl J Med. 2013; 369: 1115-1123. doi: 10.1056/NEJMoa1305520

6. Andadre-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Magee K. Heparin vs placebo in acute coronary syndrome without ST segment elevation. Cochrane Database of Syst Rev. 2014; 6: CD 003462. doi: 10.1002/14651858.CD003462.pub3

7. Bosch C, Marrugat J, Sanchis J et al. IIB/IIIA platelet glycoprotein blockers for percutaneous coronary revascularization, unstable angina and IAMSESST. Cochrane Database of Systematic Reviews 2013; Issue 11. Art. No .: CD002130. doi: 10.1002/14651858.CD002130.pub4

8. Colivicchi F, Tubaro M, Mocini D, Genovesi EA, Strano S, Melina G et al. High doses of atorvastatin versus conventional medical therapy after a STEMI in patients with non-revascularisable coronary artery disease. 2010; 26 (6): s1277-1284. doi: 10.1185/03007100375146)

9. Coto VE, Gutiérrez JL. Clinical outcomes and complications of coronary angioplasty with stent at Hospital México (Costa Rica) in the 2005-2007 period. Rev Costarr Cardiol. 2009; 11 (2): 13-19.

10. Division of Cardiology, Yonsei Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Division of cardiology, kangnam Sacred Heart Hospital, Seoul, Korea. Division of Cardiology, National Health Insurance Corporation Ilsan Hospital, Koyang, Korea. Division of Cardiology, Department of Internal Medicine, Myongjy Hospital, Kwanong University College of Medicine, Goyang, Korea. Efficacy of high doses of atorvastatin prior to primary percutaneous coronary intervention in acute myocardial infarction CEST. doi: 10.1016/j.jin.2009.11.021

11. Batista I, Alonso S, Mayo J. Primary angioplasty in acute myocardial infarction. Review article. Rev Urug Cardiol. 2013; 28: 437-451.

12. Barrabe JA, Bardajı A, Jimenez CJ, Nogal SF, Bodí V, Basterra N et al. Prognosis and Management of Acute Coronary Syndrome in Spain in 2012: The DIOCLES Study. Rev Esp Cardiol (Engl Ed). 2015; 68 (2): 98-106.

13. Palau P, Núñez J, Sanchis J, Bodí V, Rumiz E, Núñez E et al. Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction (SD). Rev Esp Cardiol. 2010; 63: 915-924. doi: 10.1016/S1885-5857 (10) 70185-7

14. Ruiz-Nodar JM, Cequier A, Lozano T et al. Representing the researchers of the GYSCA registry. Impact of the type of hospital in the treatment and evolution of patients with acute coronary syndrome without ST elevation. Spanish Journal of Cardiology. 2010; 63 (4): 390-399.

15. Swahn E, Alfredsson J. Invasive treatment of non-ST segment elevation acute coronary syndrome: cardiac catheterization / revascularization for all? Rev Esp Cardiol. 2014; 67 (03): 218-221. doi: 10.1016/j.rec.2013.11.004

16. Castro MA, Cuellas RC, Alejandro ND et al. Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with acute coronary syndrome without ST elevation. Spanish Journal of Cardiology. 2009; 62 (2): 126-135.

17. López N, Tenorio C, Franco G et al. Clinical features and one-year prognosis of patients with acute coronary syndrome without ST segment elevation and healthy coronary arteries. International Journal of Cardiology. 2011; 18 (6): 316-323.

18. Amariles P, Holguin H, Angulo NY, Betancourth PM, Ceballos M. Effect of drug clopidogrel-omeprazole interaction in hospital readmission of patients for recurrence of acute coronary syndrome: case-control study. Aten Primaria. 2014; 46 (8): 426-432.

19. Baeza RA, Latour PJ, Balsa EM et al. Using early invasive strategy in diabetic patients with acute coronary syndrome without ST elevation. Clinical Medicine. 2014; 142 (10): 427-431.

20. Latour-Pérez J, Fuset-Cabanes MP, Ruano MM et al. Using the early invasive strategy (EIP) in acute coronary syndrome without ST elevation. The paradox continues. Intensive Care Medicine. 2012; 36 (2): 95-102.

21. Rodríguez-Leor O, Fernandez-Nofrerías E, Mauri F et al. Analysis of time care in patients with acute myocardial infarction treated with primary angioplasty according to their origin and according to the schedule the procedure. Spanish Journal of Cardiology. 2011; 64 (6): 476-483.

22. Miguel-Balsa E, Baeza-Roman A, Pino-Izquierdo K et al. Predictors the use of early invasive strategy in women with acute coronary syndrome without ST elevation. Intensive Care Medicine. 2014; 38 (8): 483-491.

23. Ramírez-Marrero MA, García-Pinilla JM, Montiel-Trujillo a A, Rueda-Calle E, Alonso-Briales JH, Hernández-García JM et al. Influence of gender on prognosis of acute coronary syndrome without ST-segment elevation and the results of early interventional therapy. Cardiocore. 2014; 49 (4): 148-156.

24. SprockelJJ, Diaztagle JJ, Filizzola VC et al. Clinical description and treatment of patients with acute coronary syndrome. Acta Med Colomb. 2014; 39 (2): 124-130.

25. Peña BV, Arjona RI, Espronceda SK et al. Diagnosis and interventional treatment in patients in the General Hospital Calixto García. CorSalud. 2014; 6 (2): 148-154.

26. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. JACC. 2010; 56 (4): 254-263.

27. Kom F. Improving outcomes in acute coronary syndromes-The FRISC II Trial. Clin Cardiol. 2001; 24 (Suppl. L): 1-3-1-7.

28. Savonitto S, Morici N, De Servi S. Treatment of acute coronary syndromes in the elderly and in patients with comorbidities. Rev Esp Cardiol. 2014; 67: 564-573.

29. Moreira MH, Márcia TT, Lumenia AJ et al. Complications in patients undergoing percutaneous transluminal coronary angioplasty. 2013; 12 (3): 98-110.